Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane

Journal of Gastroenterology

Volumn 37, Issue 3, 2002, Pages 186-193

  Kishimoto, Yosuke ^a   Yashima, Kazuo ^a   Morisawa, Tsuyoshi ^a   Shiota, Goshi ^a   Kawasaki, Hironaka ^a   Hasegawa, Junichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Aberrant crypt foci; APC; c myc; COX 2; Nonsteroidal anti inflammatory drug

Indexed keywords

APC PROTEIN; AZOXYMETHANE; CYCLOOXYGENASE 2 INHIBITOR; MESSENGER RNA; MYC PROTEIN; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH PROTECTION;

ANIMALS; AZOXYMETHANE; CARCINOGENS; CARCINOMA; COLONIC NEOPLASMS; CYCLOOXYGENASE INHIBITORS; GENES, APC; GENES, MYC; IMMUNOHISTOCHEMISTRY; MALE; MODELS, ANIMAL; NITROBENZENES; RATS; RATS, INBRED F344; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONAMIDES;

EID: 0036213316     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350200019     Document Type: Article

References (35)

1. p53 mutations in flat- and polypoid-type colorectal tumors detected by temperature-gradient gel electrophoresis
2. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)
3. Cyclooxygenase (COX)-2 immunoreactivity and relationship to p53 and Ki-67 expression in colorectal cancer
4. Prospects for preventing colorectal cancer death
5. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2
6. Aberrant crypts: Potential preneoplastic lesions in the murine colon
7. Use of azoxymethane-induced foci of aberrant crypts in rat colon to identify potential cancer chemopreventive agents
8. Chemoprevention of azoxymethane-induced colon carcinogenesis by dietary feeding of S-methyl methane thiosulfonate in male F344 rats
9. Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal anti-inflammatory drug during different stages of rat colon tumor development
10. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats
11. Chemoprevention of colon carcinogenesis by sulindac, a non-steroidal anti-inflammatory agent
12. Cyclooxygenase-1 and cyclooxygenase-2 gene expression in human colorectal adenocarcinomas and in azoxymethane induced colonic tumours in rats
13. Evaluation of cyclooxygenase-2 inhibitor for potential chemopreventive properties in colon carcinogenesis
14. Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2
15. Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane
16. Sulindac sulfone inhibits K-ras-dependent cyclooxygenase-2 expression in human colon cancer cells
17. Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: An in vitro study
18. Identification of c-MYC as a target of the APC pathway
19. Effect of NS-398, a new nonsteroidal anti-inflammatory agent, on gastric ulceration and acid serection in rat
20. Nucleolar organizer regions in adenoid cystic carcinoma
21. The incidence of aberrant crypt foci and colonic carcinoma in dimethlhydrazine-treated rats varies in a site-specific manner and depends on tumor histology
22. Levels of cyclooxygenase-1 and -2 mRNA expression at various stages of acute gastric injury induced by ischemia-reperfusion in rats
23. The use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase technique: A comparison between ABC and unlabelled antibody (PAP) procedures
24. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
25. CRC and nonsteroidal anti-inflammatory drugs
26. Aspirin and gastrointestinal cancer
27. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas
28. Expression of cyclooxygenase-1 and -2 in human colorectal cancer
29. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2
30. PPARσ, is an APC-regulated target of nonsteroidal anti-inflammatory drugs
31. Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients
32. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
33. Activation of β-catenins-Tcf signaling in colon cancer by mutations in β-catenin or APC
34. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors
35. Frequent β-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis